Appendix 1: Acceptable intakes established for N-nitrosamines
Submitted by Anonymous (not verified) on 2 September 2025 - 16:03
Appendix 1: Acceptable intakes established for N-nitrosamines
Human medicines European public assessment report (EPAR): Ebilfumin, oseltamivir, Date of authorisation: 22/05/2014, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 2 September 2025 - 16:00
Human medicines European public assessment report (EPAR): Ebilfumin, oseltamivir, Date of authorisation: 22/05/2014, Revision: 16, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Syvazul BTV, bluetongue virus vaccine (inactivated) (multistrain: 1-2 strains out of a set of 3), Status: Authorised
Submitted by Anonymous (not verified) on 2 September 2025 - 15:44
Veterinary medicines European public assessment report (EPAR): Syvazul BTV, bluetongue virus vaccine (inactivated) (multistrain: 1-2 strains out of a set of 3), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Syvazul BTV 3, bluetongue virus vaccine (inactivated), Status: Authorised
Submitted by Anonymous (not verified) on 2 September 2025 - 15:30
Veterinary medicines European public assessment report (EPAR): Syvazul BTV 3, bluetongue virus vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Daxocox, enflicoxib, Status: Authorised
Submitted by Anonymous (not verified) on 2 September 2025 - 15:20
Veterinary medicines European public assessment report (EPAR): Daxocox, enflicoxib, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Nobivac LeuFel, feline leukaemia vaccine (inactivated), Status: Authorised
Submitted by Anonymous (not verified) on 2 September 2025 - 15:05
Veterinary medicines European public assessment report (EPAR): Nobivac LeuFel, feline leukaemia vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Nobivac Myxo-RHD Plus, myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 2 September 2025 - 14:59
Veterinary medicines European public assessment report (EPAR): Nobivac Myxo-RHD Plus, myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Leucogen, feline leukaemia vaccine (inactivated), Status: Authorised
Submitted by Anonymous (not verified) on 2 September 2025 - 14:55
Veterinary medicines European public assessment report (EPAR): Leucogen, feline leukaemia vaccine (inactivated), Status: Authorised
Decision of the Executive Director on rules governing the secondment of national experts to the EMA (from 1 October 2025)
Submitted by Anonymous (not verified) on 2 September 2025 - 13:15
Decision of the Executive Director on rules governing the secondment of national experts to the EMA (from 1 October 2025)
Veterinary medicines European public assessment report (EPAR): Suvaxyn CSF Marker, classical swine fever vaccine (live recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 2 September 2025 - 11:12
Veterinary medicines European public assessment report (EPAR): Suvaxyn CSF Marker, classical swine fever vaccine (live recombinant), Status: Authorised